BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36721896)

  • 1. Early Detection of Cancers in the Era of Precision Oncology.
    Tan WY; Sharma A; Das P; Ahuja N
    Curr Opin Oncol; 2023 Mar; 35(2):115-124. PubMed ID: 36721896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining developments in multicancer early detection: highlights of new clinical data from recent conferences.
    Beer TM
    Am J Manag Care; 2021 Dec; 27(19 Suppl):S347-S355. PubMed ID: 34870399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in the era of personalized oncology.
    Maitland ML; Schilsky RL
    CA Cancer J Clin; 2011; 61(6):365-81. PubMed ID: 22034206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerating precision medicine in metastatic prostate cancer.
    Mateo J; McKay R; Abida W; Aggarwal R; Alumkal J; Alva A; Feng F; Gao X; Graff J; Hussain M; Karzai F; Montgomery B; Oh W; Patel V; Rathkopf D; Rettig M; Schultz N; Smith M; Solit D; Sternberg C; Van Allen E; VanderWeele D; Vinson J; Soule HR; Chinnaiyan A; Small E; Simons JW; Dahut W; Miyahira AK; Beltran H
    Nat Cancer; 2020 Nov; 1(11):1041-1053. PubMed ID: 34258585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection and prevention of pancreatic cancer: is it really possible today?
    Del Chiaro M; Segersvärd R; Lohr M; Verbeke C
    World J Gastroenterol; 2014 Sep; 20(34):12118-31. PubMed ID: 25232247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer - the past, the present, and the future.
    Andersson R; Haglund C; Seppänen H; Ansari D
    Scand J Gastroenterol; 2022 Oct; 57(10):1169-1177. PubMed ID: 35477331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.
    Klein EA; Madhavan S; Beer TM; Bettegowda C; Liu MC; Hartman AR; Hackshaw A
    Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1003-1010. PubMed ID: 37255363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection markers in Pancreas Cancer.
    Farrell JJ; van Rijnsoever M; Elsaleh H
    Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
    Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
    JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
    Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
    Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis.
    Hibino Y; Ito M; Satake T; Kondo S
    ESMO Open; 2021 Aug; 6(4):100187. PubMed ID: 34118770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
    Fiore RN; Goodman KW
    Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.